Cargando…
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
BACKGROUND: Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Although most patients are initially sensitive to first-line combination chemotherapy with cisplatin and etoposide, chemotherapy drug resistance easily develops and quickly leads to tumour progression. Therefore...
Autores principales: | Sun, Yueqin, Shen, Weitao, Hu, Shulu, Lyu, Qiong, Wang, Qiongyao, Wei, Ting, Zhu, Weiliang, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022264/ https://www.ncbi.nlm.nih.gov/pubmed/36932427 http://dx.doi.org/10.1186/s13046-023-02638-9 |
Ejemplares similares
-
NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process
por: Shen, Weitao, et al.
Publicado: (2022) -
High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy
por: Lyu, Qiong, et al.
Publicado: (2021) -
CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter
por: Qiu, Zhengang, et al.
Publicado: (2019) -
Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells
por: Lai, Xun, et al.
Publicado: (2021) -
Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a
por: Sun, Yanqin, et al.
Publicado: (2018)